Novel nano mesoporous drug carrier material and preparation method thereof

Mesoporous nanocarbon carrier materials were prepared and molecularly modified through pulse arc and electron cyclotron resonance technology, which solved the problem that the size and shape of existing carbon material nanomedicine carrier materials were not suitable for cell phagocytosis, and achieved efficient and stable drug delivery and release Control improves the biocompatibility and safety of drug carriers.

CN118924905AInactive Publication Date: 2024-11-12GUANGZHOU MOXI TECH CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202310535460.3
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-12
Publication Date
2024-11-12
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The existing carbon material nanodrug carrier materials have problems that are not suitable for cell phagocytosis in size and shape, resulting in insufficient toxicity risk and stability, and cannot effectively solve the targeted drug delivery and release control.

Method used

The mesoporous nanocarbon carrier material is prepared by combining pulse arc technology and electron cyclotron resonance technology, and functional molecules are modified on the carrier material to form microcrystalline carbon mesoporous with high specific surface area, low cytotoxicity and excellent antioxidant properties. Nanocarbon carrier particles.

Benefits of technology

It has achieved rapid industrial mass production, improved the activity and stability of drug carrier materials, enhanced drug load and biocompatibility, reduced cytotoxicity, and had good drug release control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118924905A_ABST
    Figure CN118924905A_ABST
Patent Text Reader

Abstract

The invention relates to a novel nano-mesoporous drug carrier material and a preparation method thereof, the novel nano-mesoporous drug carrier comprises a large amount of microcrystalline carbon, oxygen functional groups on the microcrystalline carbon, molecular modifications on the oxygen functional groups and 2-20nm mesopores between the microcrystalline carbon, and the structure enables the drug carrier material to have a very high specific surface area; the compound has the advantages of good drug support and dispersibility, low cytotoxicity and excellent oxidation resistance.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a novel nano-mesoporous drug carrier material and a preparation method thereof. Background Art

[0002] Nano drug carriers are considered to be a drug delivery carrier material with broad application prospects. The improvement of drug stability and the reduction of adverse drug reactions will greatly improve the therapeutic effect of drugs. Nanoparticles encapsulate or absorb the active ingredients of drugs on their surface, which can regulate the release rate of drugs in the body and improve drug absorption. Ideal drug carriers should have the following characteristics: 1. High safety; 2. Strong loading capacity; 3. Strong targeted migration ability; 4. High bioavailability; 5. Good connection and interaction between carrier and drug.

[0003] Carbon materials, such as carbon nanotubes, graphene, Ketjen black and other new materials with at least one nanometer scale and large specific surface area, can improve drug loading capacity and provide π-π interactions to fix hydrophobic drug molecules. In addition, these carbon materials often contain rich oxygen-containing functional groups such as hydroxyl, carboxyl and epoxy groups. These active groups make them have good water solubility and stability, and are easier to modify to give them multifunctionality and specific biological activity, further improving their biocompatibility, biostability and safety. Therefore, new carbon materials are competitive nanomaterials in targeted system drug delivery systems. However, these new carbon materials have their own shortcomings. For example: graphene materials are generally large-scale two-dimensional films, which are often larger than 1 micron in size. Even a piece of graphene is larger than the size of many targeted cells. Cells cannot completely engulf graphene, which makes graphene inflammatory. Another example: carbon nanotubes, although very thin, are much longer than the size of a cell. Some of them will enter the cell, while others cannot. They are stuck on the cell and are foreign bodies with a high risk of carcinogenesis. Summary of the invention

[0004] The present invention aims to provide a novel nano-mesoporous drug carrier material and a preparation method thereof. Firstly, the pulse arc technology and the electron cyclotron resonance technology are combined to rapidly and massively produce the mesoporous nano-carbon carrier material, and then functional molecules are directly modified on the carrier material.

[0005] In order to achieve the above object, the present invention adopts the following technical solutions: A novel nano-mesoporous drug carrier material, comprising microcrystalline carbon, oxygen functional groups on the edges of microcrystalline carbon, molecular modifications on the oxygen functional groups, and 2-20 nm mesopores between microcrystalline carbon. The novel nano-mesoporous drug carrier has a high specific surface area, good drug support and dispersibility, low cytotoxicity, and excellent antioxidant properties.

[0006] The microcrystalline carbon is shaped like petals, has a flake size of 10-20 nm, and a thickness of 1-2 nm.

[0007] The mesopore size between the microcrystalline carbon is 2-20 nm, and the pores with a mesopore size <10 nm account for ≥50% of the total pore volume, the most probable (largest number) mesopore size is <3 nm, and the average pore diameter is ≤10 nm.

[0008] The specific surface area of ​​the mesoporous nano carbon carrier particles composed of microcrystalline carbon and mesopores is 800-1100 m 2 / g, total pore volume is 3~4cm 3 / g.

[0009] The microcrystalline carbon is doped with 5-10 wt.% of oxygen.

[0010] The particle size of the mesoporous nano-carbon carrier particles and the catalyst material is 200-400 nm.

[0011] The molecular modification is any one of chitosan, folic acid, carboxymethyl cellulose, polyethylene glycol, polyethylene imine, and polyacrylic acid.

[0012] The microcrystalline carbon and mesopores completely maintain their original structure and size when forming mesoporous nanocarbon carrier particles and novel nano-mesoporous drug carrier materials, wherein the microcrystalline carbon does not form agglomeration and stacking, and the mesopores do not collapse or expand.

[0013] In one embodiment, the method comprises the following steps: using arc-enhanced electron cyclotron resonance plasma as a reaction medium, using Ketjen black as a raw material, argon and neon as carrier gases, hydrogen as an etching gas, and ozone as a doping gas, to first prepare a mesoporous nano-carbon carrier particle material. Figure 3~4 shown.

[0014] 1) Using argon as carrier gas, Ketjen black (model: ECP-600) powder is transported to the pulse arc gun as a precursor (plasma gas 1). The argon gas is ionized in the arc gun to form an argon plasma arc. The high-temperature pulse arc exceeding 4000K gasifies and ionizes the Ketjen black in it to form a mixed arc of argon and carbon. The pulse arc is directly sprayed into the electron cyclotron resonance plasma chamber as a precursor for subsequent processes. Figure 3As shown in 2) the pulse time of the pulse arc is 500μs-1ms, and the duty cycle is 25~50%. 3) Hydrogen and ozone (plasma gas 2) enter the electron cyclotron resonance plasma chamber, and form a high-density pulsed plasma under the dual cracking action of electron cyclotron resonance and the aforementioned arc, which is mixed with the plasma entering the chamber in 1), and then reaches the substrate to which a stable RF bias is applied in less than the pulse time, and a mesoporous nano-carbon carrier particle material is quickly formed on the substrate. The substrate is graphite with a thickness of at least 1cm, and the carbon plasma therein forms microcrystalline carbon. Argon plasma is used to assist the gasification and ionization of Ketjen black, neon plasma is used to control the size of mesopores, hydrogen plasma is used to control the size of microcrystalline carbon, and ozone plasma is used to dope oxygen elements on microcrystalline carbon. 4) The substrate is taken out of the chamber and the mesoporous nano-carbon carrier particle material on the substrate is collected.

[0015] Compared with the prior art, the present invention has the following beneficial effects: 1) The technical method of the present invention is efficient and fast, and can achieve rapid industrial mass production. 2) The material of the present invention has a mesoporous structure and a high specific surface area, which greatly improves the activity and stability of the drug carrier material. 3) The material of the present invention has a high specific surface area and a large drug loading capacity, while also having good stability and metabolism, and no cytotoxicity.

[0016] Figure 1 , Appearance photo of the novel nano-mesoporous drug carrier material of the present invention Figure 2 TEM image of the microstructure of the novel nano-mesoporous drug carrier material of the present invention Figure 3 , Schematic diagram of the pulse arc gun used in the present invention Figure 4 Schematic diagram of the electron cyclotron resonance cavity structure used in the present invention In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings of the embodiments will be briefly introduced below. Obviously, the drawings in the following description only relate to some embodiments of the present invention, but are not intended to limit the present invention. Implementation

[0017] In order to make the purpose, technical solution and advantages of the embodiment of the present invention clearer, the technical solution of the embodiment of the present invention will be clearly and completely described below. Obviously, the described embodiment is a part of the embodiment of the present invention, not all of the embodiments. Based on the described embodiment of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0018] Unless otherwise defined, technical or scientific terms used in the present disclosure shall have the common meanings understood by those having ordinary skills in the field to which the present invention belongs.

[0019] Example 1 Preparation of a novel nano-mesoporous drug carrier material and its Zeta potential test By Figure 3 and 4 The plasma gas 1 and 2 are firstly introduced into the gas inlet with a flow rate of 1 slm to remove the air in the cavity and fill the entire cavity with argon gas, and then the argon gas flow rate is closed. Figure 3 4.33slm of argon carrier gas was introduced into the plasma port 1 shown in the figure, in which 0.1g / min of Ketjen black (model: ECP-600) was mixed, the nozzle aperture of the arc gun was 1.2mm, the current of the arc power supply was set to a pulse current of 200A, the voltage was 75V, the single pulse time was 40μs, and the duty cycle was 50%. Figure 4 As shown in the figure, hydrogen, neon and ozone gases are introduced into the two ports of each plasma. The flow rate of hydrogen is 7.79 slm, the flow rate of neon is 8.66 slm, and the flow rate of ozone is 50 sccm. The frequency of microwaves in the electron cyclotron resonance cavity is 2.45 GHz, and the initial mode of microwaves is TE 10 The rectangular mode is then converted using a microwave polarizer into a right-hand-rule TE at 2.45 GHz. 11 The circular waveguide mode is introduced by the dielectric windows around the cavity as indicated by the arrows in the figure. The power at each window is 1000W, the magnetic field strength of the multipolar magnetic field is 875G, the temperature in the resonance zone is 1600℃, the substrate is a 1cm thick graphite substrate, the RF bias on the substrate is 27MHz, 500W, and the gas pressure in the electron cyclotron resonance cavity is 1mtorr. The raw materials generate plasma in the arc gun and the electron cyclotron resonance cavity and then mix in the cavity, and quickly reach the graphite substrate to react and deposit the mesoporous nano-carbon carrier particle material. After 30 minutes, 2.85g of mesoporous nano-carbon carrier particle material is obtained, with an oxygen content of 5% and a particle size of 100nm, which is collected from the graphite substrate after being taken out.

[0020] Modify the mesoporous nano-carbon carrier particle material with molecules. Take 2.85g of folic acid and dissolve it in ethanol to prepare a folic acid ethanol solution with a concentration of 0.1%. Add the 2.85g of mesoporous nano-carbon carrier particle material collected above to the solution, and fully ultrasonically stir and disperse it for 2h. Folic acid can completely combine with the oxygen functional groups on the material to complete the molecular modification. The prepared dispersion does not need to be dried and can be directly used as a drug carrier dispersion.

[0021] Zeta potential test: At 36.7°C, 20 mg of the novel nano-mesoporous drug carrier material was taken, and after ultrasonic dispersion at 50W and 20Hz for different times, the Zeta potential of the novel nano-mesoporous drug carrier material was tested using a Zeta potential instrument. The test results are shown in the following table. Example 2 Preparation of novel nano-mesoporous drug carrier material and drug loading capacity test By Figure 3 and 4 The plasma gas 1 and 2 are firstly introduced into the gas inlet with a flow rate of 1 slm to remove the air in the cavity and fill the entire cavity with argon gas, and then the argon gas flow rate is closed. Figure 3 4.33slm of argon carrier gas was introduced into the plasma port 1 shown in the figure, in which 0.1g / min of Ketjen black (model: ECP-600) was mixed, the nozzle aperture of the arc gun was 1.2mm, the current of the arc power supply was set to a pulse current of 400A, the voltage was 37.5V, the single pulse time was 40μs, and the duty cycle was 50%. Figure 4 As shown in the figure, hydrogen, neon and ozone gases are introduced into the two ports of each plasma. The flow rate of hydrogen is 7.79 slm, the flow rate of neon is 8.66 slm, and the flow rate of ozone is 50 sccm. The frequency of microwaves in the electron cyclotron resonance cavity is 2.45 GHz, and the initial mode of microwaves is TE 10 The rectangular mode is then converted using a microwave polarizer into a right-hand-rule TE at 2.45 GHz. 11 The circular waveguide mode is introduced by the dielectric windows around the cavity as indicated by the arrows in the figure. The power at each window is 1000W, the magnetic field strength of the multipolar magnetic field is 875G, the temperature in the resonance zone is 1600℃, the substrate is a 1cm thick graphite substrate, the RF bias on the substrate is 27MHz, 500W, and the gas pressure in the electron cyclotron resonance cavity is 1mtorr. The raw materials generate plasma in the arc gun and the electron cyclotron resonance cavity and then mix in the cavity, and quickly reach the graphite substrate to react and deposit the mesoporous nano-carbon carrier particle material. After 30 minutes, 2.7g of mesoporous nano-carbon carrier particle material is obtained, with an oxygen content of 6% and a particle size of 130nm. After being taken out, it is collected from the graphite substrate.

[0022] Modify the mesoporous nano-carbon carrier particle material with molecules. Take 2.7g of polyethylene glycol and dissolve it in ethanol to prepare a polyethylene glycol ethanol solution with a concentration of 0.1%. Add the 2.7g of mesoporous nano-carbon carrier particle material collected above to the solution, and fully ultrasonically stir and disperse it for 2h. The polyethylene glycol can completely combine with the oxygen functional groups on the material to complete the molecular modification. The prepared dispersion does not need to be dried and can be directly used as a drug carrier dispersion.

[0023] Zeta potential test: At 36.7°C, 20 mg of the novel nano-mesoporous drug carrier material was taken, and after ultrasonic dispersion at 50W and 20Hz for different times, the Zeta potential of the novel nano-mesoporous drug carrier material was tested using a Zeta potential instrument. The test results are shown in the following table. Doxorubicin (DOX) was selected for drug loading test. The mobile phase of HPLC was methanol, 0.01 mol / L ammonium dihydrogen phosphate and glacial acetic acid (the volume ratio of the three was 62:38:0.5), the detection wavelength was 258 nm, and the chromatographic column was Agilent Poroshell 120 EC-C18. A series of DOX standard solutions with concentration gradients were accurately prepared, with a DOX concentration range of 0.0625-1 mg / mL. The peak area at each concentration was determined by HPLC, and a standard curve of DOX concentration-peak area was drawn with the corresponding concentration.

[0024] 5 mg of the above-mentioned novel nanoporous drug carriers were weighed and ultrasonically dispersed in 5 mL PBS buffer (pH = 7.4), and DOX solution concentrations were added at 0.2, 0.4, 0.6, 0.8, 1.0, 1.2, and 1.4 mg / mL, respectively. The reaction was stirred at room temperature in the dark for 24 h, and the unloaded drugs were removed by high-speed centrifugation. The drug peak area in the supernatant was obtained by high-performance liquid chromatography, and the drug concentration of the supernatant was obtained according to the standard curve of DOX concentration-peak area. With the increase of drug DOX concentration, the drug loading capacity of the novel nanoporous drug carrier gradually increased. When the drug concentration reached 1.2 mg / mL, the drug loading capacity had reached saturation, and the maximum drug loading capacity was 1.1163 mg / mg.

[0025] Example 3 Preparation of novel nano-mesoporous drug carrier material and drug release rate test By Figure 3 and 4 The plasma gas 1 and 2 are firstly introduced into the gas inlet with a flow rate of 1 slm to remove the air in the cavity and fill the entire cavity with argon gas, and then the argon gas flow rate is closed. Figure 3 4.33slm of argon carrier gas was introduced into the plasma port 1 shown in the figure, in which 0.1g / min of Ketjen black (model: ECP-600) was mixed. The nozzle aperture of the arc gun was 1.2mm, the current of the arc power supply was set to a pulse current of 200A, the voltage was 75V, the single pulse time was 20μs, and the duty cycle was 25%. Figure 4As shown in the figure, hydrogen, neon and ozone gases are introduced into the two ports of each plasma. The flow rate of hydrogen is 7.79 slm, the flow rate of neon is 8.66 slm, and the flow rate of ozone is 80 sccm. The frequency of microwaves in the electron cyclotron resonance cavity is 2.45 GHz, and the initial mode of microwaves is TE 10 The rectangular mode is then converted using a microwave polarizer into a right-hand-rule TE at 2.45 GHz. 11 The circular waveguide mode is introduced by the dielectric windows around the cavity as indicated by the arrows in the figure. The power at each window is 1000W, the magnetic field strength of the multipolar magnetic field is 875G, the temperature in the resonance zone is 1600℃, the substrate is a 1cm thick graphite substrate, the RF bias on the substrate is 27MHz, 500W, and the gas pressure in the electron cyclotron resonance cavity is 1mtorr. The raw materials generate plasma in the arc gun and the electron cyclotron resonance cavity and then mix in the cavity, and quickly reach the graphite substrate to react and deposit the mesoporous nano-carbon carrier particle material. After 30 minutes, 2.9g of mesoporous nano-carbon carrier particle material is obtained, with an oxygen content of 8% and a particle size of 70nm. After being taken out, it is collected from the graphite substrate.

[0026] Modify the mesoporous nano-carbon carrier particle material with molecules. Take 2.9g of polyethyleneimine and dissolve it in ethanol to prepare a polyethyleneimine ethanol solution with a concentration of 0.1%. Add the 2.9g of mesoporous nano-carbon carrier particle material collected above to the solution, and fully ultrasonically stir and disperse it for 2h. The polyethyleneimine can completely combine with the oxygen functional groups on the material to complete the molecular modification. The prepared dispersion does not need to be dried and can be directly used as a drug carrier dispersion.

[0027] Zeta potential test: At 36.7°C, 20 mg of the novel nano-mesoporous drug carrier material was taken, and after ultrasonic dispersion at 50W and 20Hz for different times, the Zeta potential of the novel nano-mesoporous drug carrier material was tested using a Zeta potential instrument. The test results are shown in the following table. In the process of drug loading of the new nano-mesoporous drug carrier material, the required loaded doxorubicin (DOX) was added to the system, and the encapsulation efficiency and drug release rate were calculated. The results showed that the drug loading was 1.1602 mg / mg, the encapsulation efficiency was 96.04%, and the sustained release of the drug could reach 72 hours, with good sustained release performance.

[0028] Example 4 Preparation of novel nano-mesoporous drug carrier material and in vitro cytotoxicity test By Figure 3 and 4 The plasma gas 1 and 2 are firstly introduced into the gas inlet with a flow rate of 1 slm to remove the air in the cavity and fill the entire cavity with argon gas, and then the argon gas flow rate is closed. Figure 34.33slm of argon carrier gas was introduced into the plasma port 1 shown in the figure, in which 0.1g / min of Ketjen black (model: ECP-600) was mixed, the nozzle aperture of the arc gun was 1.2mm, the current of the arc power supply was set to a pulse current of 200A, the voltage was 75V, the single pulse time was 40μs, and the duty cycle was 50%. Figure 4 Hydrogen, neon and ozone gases are introduced into the two ports of each plasma shown in the figure. The flow rate of hydrogen is 7.79 slm, the flow rate of neon is 8.66 slm, and the flow rate of ozone is 50 sccm. The frequency of microwaves in the electron cyclotron resonance cavity is 2.45 GHz, and the initial mode of microwaves is TE 10 The rectangular mode is then converted using a microwave polarizer into a right-hand-rule TE at 2.45 GHz. 11 The circular waveguide mode is introduced by the dielectric windows around the cavity as indicated by the arrows in the figure. The power at each window is 1000W, the magnetic field strength of the multipolar magnetic field is 875G, the temperature in the resonance zone is 1000℃, the substrate is a 1cm thick graphite substrate, the RF bias on the substrate is 27MHz, 500W, and the gas pressure in the electron cyclotron resonance cavity is 1mtorr. The raw materials generate plasma in the arc gun and the electron cyclotron resonance cavity and are mixed in the cavity to achieve the reaction deposition of mesoporous nano-carbon carrier particle material on the graphite substrate. After 30 minutes, 2.85g of mesoporous nano-carbon carrier particle material is obtained, with an oxygen content of 5% and a particle size of 100nm. After being taken out, it is collected from the graphite substrate.

[0029] Modify the mesoporous nano-carbon carrier particle material with molecules. Take 2.85g of polyethyleneimine and dissolve it in ethanol to prepare a polyethyleneimine ethanol solution with a concentration of 0.1%. Add the 2.85g of mesoporous nano-carbon carrier particle material collected above to the solution, and fully ultrasonically stir and disperse it for 2h. The polyethyleneimine can completely combine with the oxygen functional groups on the material to complete the molecular modification. The prepared dispersion does not need to be dried and can be directly used as a drug carrier dispersion.

[0030] The MTT method was used to study the in vitro cytotoxic effect of the new nanoporous drug carrier / doxorubicin (DOX) on lung cancer human alveolar basal epithelial cells (A549). A549 was inoculated into a 96-well culture plate. After culturing for 24 hours, the concentrations of the new nanoporous drug carrier were 200, 150, 100, 50, 25, and 12.5 μg / mL, respectively. After culturing the cells for 72 hours, 20 μL of MTT (5 mg / mL) was added to each well and continued to be cultured for 4-5 hours until the cells turned purple. The supernatant was removed by centrifugation, and 150 μL of dimethyl sulfoxide was added to each well. The 96-well plate was shaken for 10 minutes to fully dissolve the formazan crystals, and the light absorption value was tested at a wavelength of 570 nm using an enzyme-linked immunosorbent assay. The results showed that the new nanoporous drug carrier made the A549 cell survival rate reach 92%, indicating that the drug carrier has low cytotoxicity and good biocompatibility.

Claims

1. A novel nano-mesoporous drug carrier material, comprising microcrystalline carbon, oxygen functional groups on the edges of microcrystalline carbon, molecular modifications on the oxygen functional groups, mesopores between microcrystalline carbon, and mesoporous nano-carbon carrier particles composed of microcrystalline carbon and mesopores, wherein the mesoporous nano-carbon carrier particles are composed of novel nano-mesoporous drug carrier materials.

2. The novel nano-mesoporous drug carrier material according to claim 1, characterized in that: The microcrystalline carbon is a petal-shaped carbon nanosheet with high crystallinity, each sheet has a size of 10-20 nm, and the thickness of the microcrystalline carbon is 1-2 nm.

3. The novel nano-mesoporous drug carrier material according to claim 1, characterized in that: The particle size of the mesoporous nano-carbon carrier particles is 200-400 nm.

4. The novel nano-mesoporous drug carrier material according to claim 1, characterized in that: The mesopore size between the microcrystalline carbon is 2-20 nm, and the pores with a mesopore size <10 nm account for ≥50% of the total pore volume, the most probable (largest number) mesopore size is <3 nm, and the average pore diameter is ≤12 nm.

5. The novel nano-mesoporous drug carrier material according to claim 1, characterized in that: The specific surface area of ​​the mesoporous nanocarbon carrier particles composed of microcrystalline carbon and mesopores is 800~1100m 2 / g, total pore volume is 3~4cm 3 / g.

6. The novel nano-mesoporous drug carrier material according to claim 1, characterized in that: The microcrystalline carbon is doped with 5-10 wt.% of oxygen.

7. The novel nano-mesoporous drug carrier material according to claim 1, characterized in that: The molecular modification is any one of chitosan, folic acid, carboxymethyl cellulose, polyethylene glycol, polyethylene imine, and polyacrylic acid.

8. The novel nano-mesoporous drug carrier material according to claim 1, characterized in that: The microcrystalline carbon and mesopores completely maintain their original structure and size when forming mesoporous nanocarbon carrier particles and novel nano-mesoporous drug carrier materials, wherein the microcrystalline carbon does not form agglomeration and stacking, and the mesopores do not collapse or expand.

9. A novel nano-mesoporous drug carrier material according to claim 1, characterized in that The production process includes the following steps: using pulse arc enhanced electron cyclotron resonance plasma as the reaction medium, using Ketjen black as the raw material, argon and neon as the carrier gas, hydrogen as the etching gas, and ozone as the doping gas to first prepare the mesoporous nano-carbon carrier particle material. As shown in Figures 3 and 4 1) Using argon as carrier gas, Ketjen black (model: ECP-600) powder is transported to the pulse arc gun as a precursor (plasma gas 1). Argon is ionized by millisecond-level high-voltage pulses in the pulse arc gun to become an argon plasma arc, generating a high-temperature arc of more than 4000K to gasify and ionize the Ketjen black in it, forming a mixed arc of argon and carbon, which is directly sprayed into the electron cyclotron resonance plasma chamber as a precursor for subsequent processes. As shown in Figure 3 2) The pulse time of the pulse arc is 10μs-50μs, and the duty cycle is 25~50%. 3) Neon, hydrogen and ozone (plasma gas 2) enter the electron cyclotron resonance plasma chamber, and form a high-density pulsed plasma under the dual cracking effect of electron cyclotron resonance and the aforementioned arc, which is mixed with the plasma entering the chamber in 1), and then reaches the substrate with a stable RF bias applied in less than the pulse time, and quickly forms a mesoporous nano-carbon carrier particle material on the substrate. The substrate is graphite with a thickness of at least 1 cm, and the carbon plasma therein forms microcrystalline carbon. Argon plasma is used to assist the gasification and ionization of Ketjen black, neon plasma is used for the size regulation of mesopores, hydrogen plasma is used for the size regulation of microcrystalline carbon, and ozone plasma is used to dope oxygen elements on microcrystalline carbon. 4) The substrate is taken out of the chamber and the mesoporous nano-carbon carrier particle material on the substrate is collected.